UniProt ID | IF16_HUMAN | |
---|---|---|
UniProt AC | Q16666 | |
Protein Name | Gamma-interferon-inducible protein 16 | |
Gene Name | IFI16 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 785 | |
Subcellular Localization |
Nucleus. Cytoplasm. Cellular distribution is dependent on the acetylation status of the multipartite nuclear localization signal (NLS) NLS acetylation promotes cytoplasmic localization. Localizes in the nucleus during human herpes simplex virus 1 (H |
|
Protein Description | Binds double-stranded DNA. Binds preferentially to supercoiled DNA and cruciform DNA structures. Seems to be involved in transcriptional regulation. May function as a transcriptional repressor. Could have a role in the regulation of hematopoietic differentiation through activation of unknown target genes. Controls cellular proliferation by modulating the functions of cell cycle regulatory factors including p53/TP53 and the retinoblastoma protein. May be involved in TP53-mediated transcriptional activation by enhancing TP53 sequence-specific DNA binding and modulating TP53 phosphorylation status. Seems to be involved in energy-level-dependent activation of the ATM/ AMPK/TP53 pathway coupled to regulation of autophagy. May be involved in regulation of TP53-mediated cell death also involving BRCA1. May be involved in the senescence of prostate epithelial cells. Involved in innate immune response by recognizing viral dsDNA in the cytosol and probably in the nucleus. After binding to viral DNA in the cytoplasm recruits TMEM173/STING and mediates the induction of IFN-beta. Has anti-inflammatory activity and inhibits the activation of the AIM2 inflammasome, probably via association with AIM2. Proposed to bind viral DNA in the nucleus, such as of Kaposi's sarcoma-associated herpesvirus, and to induce the formation of nuclear caspase-1-activating inflammasome formation via association with PYCARD. Inhibits replication of herpesviruses such as human cytomegalovirus (HCMV) probably by interfering with promoter recruitment of members of the Sp1 family of transcription factors. Necessary to activate the IRF3 signaling cascade during human herpes simplex virus 1 (HHV-1) infection and promotes the assembly of heterochromatin on herpesviral DNA and inhibition of viral immediate-early gene expression and replication. Involved in the MTA1-mediated epigenetic regulation of ESR1 expression in breast cancer.. | |
Protein Sequence | MGKKYKNIVLLKGLEVINDYHFRMVKSLLSNDLKLNLKMREEYDKIQIADLMEEKFRGDAGLGKLIKIFEDIPTLEDLAETLKKEKLKVKGPALSRKRKKEVDATSPAPSTSSTVKTEGAEATPGAQKRKKSTKEKAGPKGSKVSEEQTQPPSPAGAGMSTAMGRSPSPKTSLSAPPNSSSTENPKTVAKCQVTPRRNVLQKRPVIVKVLSTTKPFEYETPEMEKKIMFHATVATQTQFFHVKVLNTSLKEKFNGKKIIIISDYLEYDSLLEVNEESTVSEAGPNQTFEVPNKIINRAKETLKIDILHKQASGNIVYGVFMLHKKTVNQKTTIYEIQDDRGKMDVVGTGQCHNIPCEEGDKLQLFCFRLRKKNQMSKLISEMHSFIQIKKKTNPRNNDPKSMKLPQEQRQLPYPSEASTTFPESHLRTPQMPPTTPSSSFFTKKSEDTISKMNDFMRMQILKEGSHFPGPFMTSIGPAESHPHTPQMPPSTPSSSFLTTKSEDTISKMNDFMRMQILKEGSHFPGPFMTSIGPAESHPHTPQMPPSTPSSSFLTTLKPRLKTEPEEVSIEDSAQSDLKEVMVLNATESFVYEPKEQKKMFHATVATENEVFRVKVFNIDLKEKFTPKKIIAIANYVCRNGFLEVYPFTLVADVNADRNMEIPKGLIRSASVTPKINQLCSQTKGSFVNGVFEVHKKNVRGEFTYYEIQDNTGKMEVVVHGRLTTINCEEGDKLKLTCFELAPKSGNTGELRSVIHSHIKVIKTRKNKKDILNPDSSMETSPDFFF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Ubiquitination | --MGKKYKNIVLLKG --CCCCCCCEEEEEC | 49.42 | 29967540 | |
20 | Phosphorylation | GLEVINDYHFRMVKS CHHEECHHHHHHHHH | 9.81 | - | |
26 | Acetylation | DYHFRMVKSLLSNDL HHHHHHHHHHHCCCH | 26.50 | 25953088 | |
26 | Ubiquitination | DYHFRMVKSLLSNDL HHHHHHHHHHHCCCH | 26.50 | - | |
34 | Ubiquitination | SLLSNDLKLNLKMRE HHHCCCHHHCHHHHH | 37.89 | 32015554 | |
45 | Acetylation | KMREEYDKIQIADLM HHHHHHHHHCHHHHH | 35.29 | 22691496 | |
55 | 2-Hydroxyisobutyrylation | IADLMEEKFRGDAGL HHHHHHHHHCCCCCH | 27.36 | - | |
55 | Ubiquitination | IADLMEEKFRGDAGL HHHHHHHHHCCCCCH | 27.36 | 29967540 | |
64 | Acetylation | RGDAGLGKLIKIFED CCCCCHHHHHHHHCC | 52.67 | 23749302 | |
64 | Ubiquitination | RGDAGLGKLIKIFED CCCCCHHHHHHHHCC | 52.67 | 22505724 | |
67 | Ubiquitination | AGLGKLIKIFEDIPT CCHHHHHHHHCCCCC | 52.35 | 29967540 | |
68 | Ubiquitination | GLGKLIKIFEDIPTL CHHHHHHHHCCCCCH | 3.47 | 22505724 | |
74 | Phosphorylation | KIFEDIPTLEDLAET HHHCCCCCHHHHHHH | 43.01 | 25338102 | |
83 | Sumoylation | EDLAETLKKEKLKVK HHHHHHHHHHHCCCC | 67.32 | - | |
83 | Ubiquitination | EDLAETLKKEKLKVK HHHHHHHHHHHCCCC | 67.32 | 21906983 | |
83 (in isoform 1) | Ubiquitination | - | 67.32 | 21906983 | |
83 (in isoform 2) | Ubiquitination | - | 67.32 | 21906983 | |
83 (in isoform 3) | Ubiquitination | - | 67.32 | 21906983 | |
84 | Ubiquitination | DLAETLKKEKLKVKG HHHHHHHHHHCCCCC | 64.29 | 22817900 | |
86 | Acetylation | AETLKKEKLKVKGPA HHHHHHHHCCCCCHH | 63.59 | 69243 | |
86 | Ubiquitination | AETLKKEKLKVKGPA HHHHHHHHCCCCCHH | 63.59 | 22817900 | |
87 | Ubiquitination | ETLKKEKLKVKGPAL HHHHHHHCCCCCHHH | 8.93 | 22817900 | |
88 | Ubiquitination | TLKKEKLKVKGPALS HHHHHHCCCCCHHHC | 53.63 | 22817900 | |
90 | Ubiquitination | KKEKLKVKGPALSRK HHHHCCCCCHHHCCC | 58.55 | 22817900 | |
92 | Ubiquitination | EKLKVKGPALSRKRK HHCCCCCHHHCCCCC | 25.06 | 22817900 | |
94 | Ubiquitination | LKVKGPALSRKRKKE CCCCCHHHCCCCCCC | 5.99 | 22505724 | |
95 | Phosphorylation | KVKGPALSRKRKKEV CCCCHHHCCCCCCCC | 37.55 | 22691496 | |
97 | Ubiquitination | KGPALSRKRKKEVDA CCHHHCCCCCCCCCC | 66.26 | 22817900 | |
99 | Acetylation | PALSRKRKKEVDATS HHHCCCCCCCCCCCC | 57.21 | 22691496 | |
99 | Ubiquitination | PALSRKRKKEVDATS HHHCCCCCCCCCCCC | 57.21 | 21963094 | |
100 | Ubiquitination | ALSRKRKKEVDATSP HHCCCCCCCCCCCCC | 67.98 | 22817900 | |
101 | Ubiquitination | LSRKRKKEVDATSPA HCCCCCCCCCCCCCC | 48.98 | 22817900 | |
103 | Ubiquitination | RKRKKEVDATSPAPS CCCCCCCCCCCCCCC | 45.26 | 21963094 | |
104 | Ubiquitination | KRKKEVDATSPAPST CCCCCCCCCCCCCCC | 18.36 | 22817900 | |
105 | Phosphorylation | RKKEVDATSPAPSTS CCCCCCCCCCCCCCC | 30.68 | 29255136 | |
106 | Phosphorylation | KKEVDATSPAPSTSS CCCCCCCCCCCCCCC | 22.30 | 29255136 | |
110 | Phosphorylation | DATSPAPSTSSTVKT CCCCCCCCCCCCCCC | 42.92 | 30266825 | |
111 | Phosphorylation | ATSPAPSTSSTVKTE CCCCCCCCCCCCCCC | 26.15 | 30266825 | |
112 | Phosphorylation | TSPAPSTSSTVKTEG CCCCCCCCCCCCCCC | 28.48 | 30266825 | |
113 | Phosphorylation | SPAPSTSSTVKTEGA CCCCCCCCCCCCCCC | 36.99 | 30266825 | |
114 | Phosphorylation | PAPSTSSTVKTEGAE CCCCCCCCCCCCCCC | 26.28 | 30266825 | |
116 | Sumoylation | PSTSSTVKTEGAEAT CCCCCCCCCCCCCCC | 40.73 | - | |
116 | Acetylation | PSTSSTVKTEGAEAT CCCCCCCCCCCCCCC | 40.73 | 26051181 | |
116 | Sumoylation | PSTSSTVKTEGAEAT CCCCCCCCCCCCCCC | 40.73 | 28112733 | |
116 | Ubiquitination | PSTSSTVKTEGAEAT CCCCCCCCCCCCCCC | 40.73 | 21963094 | |
117 | Phosphorylation | STSSTVKTEGAEATP CCCCCCCCCCCCCCC | 35.00 | 23403867 | |
120 | Ubiquitination | STVKTEGAEATPGAQ CCCCCCCCCCCCCCH | 9.30 | 21963094 | |
123 | Phosphorylation | KTEGAEATPGAQKRK CCCCCCCCCCCHHCC | 17.48 | 29255136 | |
128 | Acetylation | EATPGAQKRKKSTKE CCCCCCHHCCCCHHC | 66.70 | 22691496 | |
128 | Sumoylation | EATPGAQKRKKSTKE CCCCCCHHCCCCHHC | 66.70 | 28112733 | |
128 | Ubiquitination | EATPGAQKRKKSTKE CCCCCCHHCCCCHHC | 66.70 | 21906983 | |
128 (in isoform 1) | Ubiquitination | - | 66.70 | 21906983 | |
128 (in isoform 2) | Ubiquitination | - | 66.70 | 21906983 | |
128 (in isoform 3) | Ubiquitination | - | 66.70 | 21906983 | |
130 | Ubiquitination | TPGAQKRKKSTKEKA CCCCHHCCCCHHCCC | 59.10 | 22817900 | |
131 | Ubiquitination | PGAQKRKKSTKEKAG CCCHHCCCCHHCCCC | 68.35 | 22817900 | |
132 | Phosphorylation | GAQKRKKSTKEKAGP CCHHCCCCHHCCCCC | 47.98 | 26670566 | |
132 | Ubiquitination | GAQKRKKSTKEKAGP CCHHCCCCHHCCCCC | 47.98 | 22817900 | |
133 | Phosphorylation | AQKRKKSTKEKAGPK CHHCCCCHHCCCCCC | 52.69 | 26670566 | |
134 | Ubiquitination | QKRKKSTKEKAGPKG HHCCCCHHCCCCCCC | 65.39 | 22817900 | |
135 | Ubiquitination | KRKKSTKEKAGPKGS HCCCCHHCCCCCCCC | 48.50 | 22817900 | |
140 | Ubiquitination | TKEKAGPKGSKVSEE HHCCCCCCCCCCCHH | 74.93 | 24816145 | |
142 | Phosphorylation | EKAGPKGSKVSEEQT CCCCCCCCCCCHHHC | 35.69 | 30108239 | |
143 | Acetylation | KAGPKGSKVSEEQTQ CCCCCCCCCCHHHCC | 59.45 | 25953088 | |
143 | Ubiquitination | KAGPKGSKVSEEQTQ CCCCCCCCCCHHHCC | 59.45 | 22505724 | |
144 | Ubiquitination | AGPKGSKVSEEQTQP CCCCCCCCCHHHCCC | 10.49 | 24816145 | |
145 | Phosphorylation | GPKGSKVSEEQTQPP CCCCCCCCHHHCCCC | 38.87 | 23927012 | |
146 | Ubiquitination | PKGSKVSEEQTQPPS CCCCCCCHHHCCCCC | 58.05 | 29967540 | |
147 | Ubiquitination | KGSKVSEEQTQPPSP CCCCCCHHHCCCCCC | 51.96 | 22505724 | |
149 | Phosphorylation | SKVSEEQTQPPSPAG CCCCHHHCCCCCCCC | 46.45 | 25159151 | |
152 | Acetylation | SEEQTQPPSPAGAGM CHHHCCCCCCCCCCC | 43.03 | 19608861 | |
152 | Ubiquitination | SEEQTQPPSPAGAGM CHHHCCCCCCCCCCC | 43.03 | 29967540 | |
153 | Phosphorylation | EEQTQPPSPAGAGMS HHHCCCCCCCCCCCC | 33.78 | 29255136 | |
158 | Acetylation | PPSPAGAGMSTAMGR CCCCCCCCCCCCCCC | 15.06 | 19608861 | |
158 | Ubiquitination | PPSPAGAGMSTAMGR CCCCCCCCCCCCCCC | 15.06 | 29967540 | |
160 | Phosphorylation | SPAGAGMSTAMGRSP CCCCCCCCCCCCCCC | 16.46 | 23927012 | |
161 | Phosphorylation | PAGAGMSTAMGRSPS CCCCCCCCCCCCCCC | 16.27 | 23401153 | |
166 | Phosphorylation | MSTAMGRSPSPKTSL CCCCCCCCCCCCCCC | 24.81 | 25159151 | |
168 | Phosphorylation | TAMGRSPSPKTSLSA CCCCCCCCCCCCCCC | 40.03 | 28355574 | |
169 | Ubiquitination | AMGRSPSPKTSLSAP CCCCCCCCCCCCCCC | 47.53 | 29967540 | |
171 | Phosphorylation | GRSPSPKTSLSAPPN CCCCCCCCCCCCCCC | 37.98 | 27486199 | |
172 | Phosphorylation | RSPSPKTSLSAPPNS CCCCCCCCCCCCCCC | 26.84 | 27251275 | |
174 | Phosphorylation | PSPKTSLSAPPNSSS CCCCCCCCCCCCCCC | 38.20 | 22691496 | |
179 | Phosphorylation | SLSAPPNSSSTENPK CCCCCCCCCCCCCCC | 31.29 | 27486199 | |
180 | Phosphorylation | LSAPPNSSSTENPKT CCCCCCCCCCCCCCC | 48.17 | 27486199 | |
181 | Phosphorylation | SAPPNSSSTENPKTV CCCCCCCCCCCCCCE | 39.29 | 27486199 | |
182 | Phosphorylation | APPNSSSTENPKTVA CCCCCCCCCCCCCEE | 41.55 | 27486199 | |
190 | Sumoylation | ENPKTVAKCQVTPRR CCCCCEEECEECCCC | 22.36 | - | |
190 | Acetylation | ENPKTVAKCQVTPRR CCCCCEEECEECCCC | 22.36 | 25953088 | |
190 | Ubiquitination | ENPKTVAKCQVTPRR CCCCCEEECEECCCC | 22.36 | 22505724 | |
194 | Phosphorylation | TVAKCQVTPRRNVLQ CEEECEECCCCCHHH | 5.79 | 21815630 | |
194 | Ubiquitination | TVAKCQVTPRRNVLQ CEEECEECCCCCHHH | 5.79 | 22817900 | |
196 | Ubiquitination | AKCQVTPRRNVLQKR EECEECCCCCHHHCC | 33.18 | 22817900 | |
202 | Acetylation | PRRNVLQKRPVIVKV CCCCHHHCCCEEEEE | 55.28 | 25953088 | |
202 | Ubiquitination | PRRNVLQKRPVIVKV CCCCHHHCCCEEEEE | 55.28 | 29967540 | |
208 | Acetylation | QKRPVIVKVLSTTKP HCCCEEEEECCCCCC | 26.74 | 26051181 | |
208 | Ubiquitination | QKRPVIVKVLSTTKP HCCCEEEEECCCCCC | 26.74 | 29967540 | |
211 | Phosphorylation | PVIVKVLSTTKPFEY CEEEEECCCCCCCCC | 36.70 | 23312004 | |
212 | Phosphorylation | VIVKVLSTTKPFEYE EEEEECCCCCCCCCC | 34.38 | 23312004 | |
213 | Phosphorylation | IVKVLSTTKPFEYET EEEECCCCCCCCCCC | 33.09 | 23312004 | |
214 | Acetylation | VKVLSTTKPFEYETP EEECCCCCCCCCCCH | 48.04 | 22691496 | |
214 | Malonylation | VKVLSTTKPFEYETP EEECCCCCCCCCCCH | 48.04 | 26320211 | |
214 | Ubiquitination | VKVLSTTKPFEYETP EEECCCCCCCCCCCH | 48.04 | 29967540 | |
218 | Phosphorylation | STTKPFEYETPEMEK CCCCCCCCCCHHHHH | 26.02 | 23312004 | |
220 | Phosphorylation | TKPFEYETPEMEKKI CCCCCCCCHHHHHHH | 24.52 | 23312004 | |
225 | Acetylation | YETPEMEKKIMFHAT CCCHHHHHHHEEEEE | 46.41 | 25953088 | |
225 | Ubiquitination | YETPEMEKKIMFHAT CCCHHHHHHHEEEEE | 46.41 | 29967540 | |
226 | Ubiquitination | ETPEMEKKIMFHATV CCHHHHHHHEEEEEE | 26.54 | - | |
232 | Phosphorylation | KKIMFHATVATQTQF HHHEEEEEEEECCCE | 11.34 | - | |
237 | Phosphorylation | HATVATQTQFFHVKV EEEEEECCCEEEEEE | 24.00 | - | |
243 | Ubiquitination | QTQFFHVKVLNTSLK CCCEEEEEEECHHHH | 32.22 | 29967540 | |
247 | Ubiquitination | FHVKVLNTSLKEKFN EEEEEECHHHHHHHC | 31.13 | 29967540 | |
248 | Phosphorylation | HVKVLNTSLKEKFNG EEEEECHHHHHHHCC | 36.05 | - | |
250 | Acetylation | KVLNTSLKEKFNGKK EEECHHHHHHHCCEE | 59.64 | 25953088 | |
250 | Malonylation | KVLNTSLKEKFNGKK EEECHHHHHHHCCEE | 59.64 | 26320211 | |
250 | Ubiquitination | KVLNTSLKEKFNGKK EEECHHHHHHHCCEE | 59.64 | 21906983 | |
250 (in isoform 1) | Ubiquitination | - | 59.64 | 21906983 | |
250 (in isoform 2) | Ubiquitination | - | 59.64 | 21906983 | |
250 (in isoform 3) | Ubiquitination | - | 59.64 | 21906983 | |
252 | Ubiquitination | LNTSLKEKFNGKKII ECHHHHHHHCCEEEE | 42.41 | 22817900 | |
254 | Ubiquitination | TSLKEKFNGKKIIII HHHHHHHCCEEEEEE | 72.88 | 22817900 | |
256 | Ubiquitination | LKEKFNGKKIIIISD HHHHHCCEEEEEEEC | 41.73 | 22817900 | |
269 | Ubiquitination | SDYLEYDSLLEVNEE ECCCCCHHCEEECCC | 33.67 | 22817900 | |
274 | Ubiquitination | YDSLLEVNEESTVSE CHHCEEECCCCCCCC | 37.63 | 21963094 | |
286 | Ubiquitination | VSEAGPNQTFEVPNK CCCCCCCCCEECCHH | 51.18 | 29967540 | |
299 | Ubiquitination | NKIINRAKETLKIDI HHHHHHHHHHHCEEE | 48.25 | 29967540 | |
303 | Ubiquitination | NRAKETLKIDILHKQ HHHHHHHCEEEEEEC | 45.83 | 29967540 | |
305 | Ubiquitination | AKETLKIDILHKQAS HHHHHCEEEEEECCC | 35.49 | 29967540 | |
317 | Phosphorylation | QASGNIVYGVFMLHK CCCCCEEEEEEEEEE | 12.08 | - | |
321 | Ubiquitination | NIVYGVFMLHKKTVN CEEEEEEEEEECCCC | 3.39 | 29967540 | |
324 | Acetylation | YGVFMLHKKTVNQKT EEEEEEEECCCCCCE | 46.29 | 25953088 | |
325 | Ubiquitination | GVFMLHKKTVNQKTT EEEEEEECCCCCCEE | 47.13 | 22817900 | |
329 | Ubiquitination | LHKKTVNQKTTIYEI EEECCCCCCEEEEEE | 39.89 | 22817900 | |
330 | Acetylation | HKKTVNQKTTIYEIQ EECCCCCCEEEEEEE | 42.29 | 25953088 | |
330 | Malonylation | HKKTVNQKTTIYEIQ EECCCCCCEEEEEEE | 42.29 | 26320211 | |
330 | Ubiquitination | HKKTVNQKTTIYEIQ EECCCCCCEEEEEEE | 42.29 | 21963094 | |
332 | Phosphorylation | KTVNQKTTIYEIQDD CCCCCCEEEEEEECC | 28.70 | 24719451 | |
333 | Ubiquitination | TVNQKTTIYEIQDDR CCCCCEEEEEEECCC | 3.34 | 29967540 | |
334 | Phosphorylation | VNQKTTIYEIQDDRG CCCCEEEEEEECCCC | 12.60 | 24719451 | |
334 | Ubiquitination | VNQKTTIYEIQDDRG CCCCEEEEEEECCCC | 12.60 | 21963094 | |
342 | Acetylation | EIQDDRGKMDVVGTG EEECCCCCEEEEECC | 32.59 | 25953088 | |
342 | Ubiquitination | EIQDDRGKMDVVGTG EEECCCCCEEEEECC | 32.59 | 29967540 | |
344 | Ubiquitination | QDDRGKMDVVGTGQC ECCCCCEEEEECCCC | 35.12 | 29967540 | |
361 | Acetylation | IPCEEGDKLQLFCFR CCCCCCCEEEEEEEE | 49.33 | 25953088 | |
361 | Ubiquitination | IPCEEGDKLQLFCFR CCCCCCCEEEEEEEE | 49.33 | 29967540 | |
363 | Phosphorylation | CEEGDKLQLFCFRLR CCCCCEEEEEEEEHH | 37.93 | 27251275 | |
377 | Acetylation | RKKNQMSKLISEMHS HHHCHHHHHHHHHHH | 44.49 | 23749302 | |
377 | Ubiquitination | RKKNQMSKLISEMHS HHHCHHHHHHHHHHH | 44.49 | 29967540 | |
387 | Ubiquitination | SEMHSFIQIKKKTNP HHHHHHHHHHHCCCC | 39.16 | 22505724 | |
388 | Ubiquitination | EMHSFIQIKKKTNPR HHHHHHHHHHCCCCC | 6.37 | 29967540 | |
389 | Acetylation | MHSFIQIKKKTNPRN HHHHHHHHHCCCCCC | 31.66 | 25953088 | |
389 | Malonylation | MHSFIQIKKKTNPRN HHHHHHHHHCCCCCC | 31.66 | 26320211 | |
389 | Ubiquitination | MHSFIQIKKKTNPRN HHHHHHHHHCCCCCC | 31.66 | 29967540 | |
395 | Ubiquitination | IKKKTNPRNNDPKSM HHHCCCCCCCCCCCC | 57.57 | 22505724 | |
400 | Acetylation | NPRNNDPKSMKLPQE CCCCCCCCCCCCCHH | 67.08 | 23749302 | |
400 | Ubiquitination | NPRNNDPKSMKLPQE CCCCCCCCCCCCCHH | 67.08 | 29967540 | |
406 | Ubiquitination | PKSMKLPQEQRQLPY CCCCCCCHHHCCCCC | 70.64 | 29967540 | |
418 | Phosphorylation | LPYPSEASTTFPESH CCCCCCCCCCCCHHH | 24.75 | 25159151 | |
419 | Phosphorylation | PYPSEASTTFPESHL CCCCCCCCCCCHHHC | 39.23 | 25159151 | |
428 | Phosphorylation | FPESHLRTPQMPPTT CCHHHCCCCCCCCCC | 25.00 | 21815630 | |
431 | Sulfoxidation | SHLRTPQMPPTTPSS HHCCCCCCCCCCCCC | 4.52 | 28465586 | |
434 | Phosphorylation | RTPQMPPTTPSSSFF CCCCCCCCCCCCCCC | 45.53 | 21815630 | |
435 | Phosphorylation | TPQMPPTTPSSSFFT CCCCCCCCCCCCCCC | 27.26 | 25159151 | |
437 | Phosphorylation | QMPPTTPSSSFFTKK CCCCCCCCCCCCCCC | 36.20 | 21815630 | |
438 | Phosphorylation | MPPTTPSSSFFTKKS CCCCCCCCCCCCCCC | 32.16 | 29396449 | |
439 | Phosphorylation | PPTTPSSSFFTKKSE CCCCCCCCCCCCCCH | 28.81 | 29396449 | |
442 | Phosphorylation | TPSSSFFTKKSEDTI CCCCCCCCCCCHHHH | 35.24 | 29396449 | |
443 | Methylation | PSSSFFTKKSEDTIS CCCCCCCCCCHHHHH | 49.50 | 115971349 | |
443 | Ubiquitination | PSSSFFTKKSEDTIS CCCCCCCCCCHHHHH | 49.50 | 22505724 | |
443 (in isoform 3) | Ubiquitination | - | 49.50 | - | |
444 | Sumoylation | SSSFFTKKSEDTISK CCCCCCCCCHHHHHH | 56.89 | - | |
444 | Acetylation | SSSFFTKKSEDTISK CCCCCCCCCHHHHHH | 56.89 | 22691496 | |
444 | Ubiquitination | SSSFFTKKSEDTISK CCCCCCCCCHHHHHH | 56.89 | 29967540 | |
447 | Ubiquitination | FFTKKSEDTISKMND CCCCCCHHHHHHHHH | 57.33 | 22505724 | |
448 | Phosphorylation | FTKKSEDTISKMNDF CCCCCHHHHHHHHHH | 24.09 | 30576142 | |
449 | Ubiquitination | TKKSEDTISKMNDFM CCCCHHHHHHHHHHH | 6.03 | 22817900 | |
451 | Sumoylation | KSEDTISKMNDFMRM CCHHHHHHHHHHHHH | 37.56 | - | |
451 | Acetylation | KSEDTISKMNDFMRM CCHHHHHHHHHHHHH | 37.56 | 22691496 | |
451 | Ubiquitination | KSEDTISKMNDFMRM CCHHHHHHHHHHHHH | 37.56 | 22505724 | |
453 | Ubiquitination | EDTISKMNDFMRMQI HHHHHHHHHHHHHHH | 43.00 | 22817900 | |
455 | Ubiquitination | TISKMNDFMRMQILK HHHHHHHHHHHHHHH | 2.58 | 22505724 | |
456 (in isoform 3) | Phosphorylation | - | 3.78 | 29507054 | |
462 | Ubiquitination | FMRMQILKEGSHFPG HHHHHHHHCCCCCCC | 62.75 | 29967540 | |
465 | Phosphorylation | MQILKEGSHFPGPFM HHHHHCCCCCCCCCC | 24.05 | 26714015 | |
473 | Phosphorylation | HFPGPFMTSIGPAES CCCCCCCCCCCCCCC | 19.99 | 26074081 | |
474 | Phosphorylation | FPGPFMTSIGPAESH CCCCCCCCCCCCCCC | 17.48 | 26074081 | |
480 | Phosphorylation | TSIGPAESHPHTPQM CCCCCCCCCCCCCCC | 44.41 | 25159151 | |
484 | Phosphorylation | PAESHPHTPQMPPST CCCCCCCCCCCCCCC | 21.48 | 25159151 | |
490 | Phosphorylation | HTPQMPPSTPSSSFL CCCCCCCCCCCCCCC | 47.26 | 25159151 | |
490 | Ubiquitination | HTPQMPPSTPSSSFL CCCCCCCCCCCCCCC | 47.26 | 22505724 | |
491 | Phosphorylation | TPQMPPSTPSSSFLT CCCCCCCCCCCCCCC | 32.72 | 25159151 | |
493 | Phosphorylation | QMPPSTPSSSFLTTK CCCCCCCCCCCCCCC | 38.41 | 25159151 | |
494 | Phosphorylation | MPPSTPSSSFLTTKS CCCCCCCCCCCCCCC | 26.72 | 26074081 | |
495 | Phosphorylation | PPSTPSSSFLTTKSE CCCCCCCCCCCCCCH | 28.72 | 26074081 | |
499 | Phosphorylation | PSSSFLTTKSEDTIS CCCCCCCCCCHHHHH | 34.42 | 26714015 | |
500 | Sumoylation | SSSFLTTKSEDTISK CCCCCCCCCHHHHHH | 46.76 | - | |
501 | Phosphorylation | SSFLTTKSEDTISKM CCCCCCCCHHHHHHH | 38.32 | 22210691 | |
501 | Ubiquitination | SSFLTTKSEDTISKM CCCCCCCCHHHHHHH | 38.32 | 22817900 | |
505 | Ubiquitination | TTKSEDTISKMNDFM CCCCHHHHHHHHHHH | 6.03 | 32015554 | |
506 | Ubiquitination | TKSEDTISKMNDFMR CCCHHHHHHHHHHHH | 28.13 | 23000965 | |
507 | Sumoylation | KSEDTISKMNDFMRM CCHHHHHHHHHHHHH | 37.56 | - | |
507 | Acetylation | KSEDTISKMNDFMRM CCHHHHHHHHHHHHH | 37.56 | 25953088 | |
507 | Ubiquitination | KSEDTISKMNDFMRM CCHHHHHHHHHHHHH | 37.56 | - | |
511 | Ubiquitination | TISKMNDFMRMQILK HHHHHHHHHHHHHHH | 2.58 | 22505724 | |
512 | Phosphorylation | ISKMNDFMRMQILKE HHHHHHHHHHHHHHC | 3.78 | 27251275 | |
513 | Ubiquitination | SKMNDFMRMQILKEG HHHHHHHHHHHHHCC | 17.53 | 22505724 | |
515 | Ubiquitination | MNDFMRMQILKEGSH HHHHHHHHHHHCCCC | 27.74 | 22505724 | |
516 | Phosphorylation | NDFMRMQILKEGSHF HHHHHHHHHHCCCCC | 4.30 | 27251275 | |
519 | Phosphorylation | MRMQILKEGSHFPGP HHHHHHHCCCCCCCC | 63.58 | 20068231 | |
520 | Ubiquitination | RMQILKEGSHFPGPF HHHHHHCCCCCCCCC | 25.49 | 22505724 | |
529 | Phosphorylation | HFPGPFMTSIGPAES CCCCCCCCCCCCCCC | 19.99 | 26074081 | |
530 | Phosphorylation | FPGPFMTSIGPAESH CCCCCCCCCCCCCCC | 17.48 | 26074081 | |
536 | Phosphorylation | TSIGPAESHPHTPQM CCCCCCCCCCCCCCC | 44.41 | 25627689 | |
540 | Phosphorylation | PAESHPHTPQMPPST CCCCCCCCCCCCCCC | 21.48 | 25627689 | |
542 | Ubiquitination | ESHPHTPQMPPSTPS CCCCCCCCCCCCCCC | 59.16 | 22505724 | |
546 | Phosphorylation | HTPQMPPSTPSSSFL CCCCCCCCCCCCCCC | 47.26 | 30576142 | |
547 | Phosphorylation | TPQMPPSTPSSSFLT CCCCCCCCCCCCCCC | 32.72 | 25627689 | |
549 | Phosphorylation | QMPPSTPSSSFLTTL CCCCCCCCCCCCCCC | 38.41 | 26074081 | |
550 | Phosphorylation | MPPSTPSSSFLTTLK CCCCCCCCCCCCCCC | 26.72 | 26074081 | |
551 | Phosphorylation | PPSTPSSSFLTTLKP CCCCCCCCCCCCCCC | 28.72 | 26074081 | |
554 | Phosphorylation | TPSSSFLTTLKPRLK CCCCCCCCCCCCCCC | 28.24 | 28634298 | |
555 | Phosphorylation | PSSSFLTTLKPRLKT CCCCCCCCCCCCCCC | 34.63 | 28634298 | |
555 | Ubiquitination | PSSSFLTTLKPRLKT CCCCCCCCCCCCCCC | 34.63 | 24816145 | |
557 | Acetylation | SSFLTTLKPRLKTEP CCCCCCCCCCCCCCC | 26.46 | 25953088 | |
557 | Ubiquitination | SSFLTTLKPRLKTEP CCCCCCCCCCCCCCC | 26.46 | - | |
558 | Ubiquitination | SFLTTLKPRLKTEPE CCCCCCCCCCCCCCC | 50.37 | 23000965 | |
561 | Sumoylation | TTLKPRLKTEPEEVS CCCCCCCCCCCCCCC | 52.72 | - | |
561 | Acetylation | TTLKPRLKTEPEEVS CCCCCCCCCCCCCCC | 52.72 | 22691496 | |
561 | Sumoylation | TTLKPRLKTEPEEVS CCCCCCCCCCCCCCC | 52.72 | 25114211 | |
561 | Ubiquitination | TTLKPRLKTEPEEVS CCCCCCCCCCCCCCC | 52.72 | 22817900 | |
562 | Phosphorylation | TLKPRLKTEPEEVSI CCCCCCCCCCCCCCH | 62.45 | 28122231 | |
562 (in isoform 3) | Ubiquitination | - | 62.45 | 21906983 | |
565 | Ubiquitination | PRLKTEPEEVSIEDS CCCCCCCCCCCHHHH | 65.87 | 22817900 | |
566 | Ubiquitination | RLKTEPEEVSIEDSA CCCCCCCCCCHHHHC | 52.89 | 22817900 | |
567 | Ubiquitination | LKTEPEEVSIEDSAQ CCCCCCCCCHHHHCC | 7.14 | 22505724 | |
568 | Phosphorylation | KTEPEEVSIEDSAQS CCCCCCCCHHHHCCC | 24.44 | 25159151 | |
572 | Phosphorylation | EEVSIEDSAQSDLKE CCCCHHHHCCCCCCC | 18.54 | 25159151 | |
572 | Ubiquitination | EEVSIEDSAQSDLKE CCCCHHHHCCCCCCC | 18.54 | 22505724 | |
575 | Phosphorylation | SIEDSAQSDLKEVMV CHHHHCCCCCCCEEE | 44.63 | 25159151 | |
583 (in isoform 3) | Ubiquitination | - | 1.63 | 21906983 | |
586 | Phosphorylation | EVMVLNATESFVYEP CEEEEECCCCEECCC | 30.96 | 28122231 | |
587 | Ubiquitination | VMVLNATESFVYEPK EEEEECCCCEECCCH | 39.51 | 22817900 | |
588 | Ubiquitination | MVLNATESFVYEPKE EEEECCCCEECCCHH | 18.69 | 22817900 | |
598 | Sumoylation | YEPKEQKKMFHATVA CCCHHHHHCEEEEEE | 46.63 | - | |
598 | Acetylation | YEPKEQKKMFHATVA CCCHHHHHCEEEEEE | 46.63 | 22691496 | |
598 | Ubiquitination | YEPKEQKKMFHATVA CCCHHHHHCEEEEEE | 46.63 | - | |
602 | Ubiquitination | EQKKMFHATVATENE HHHHCEEEEEECCCC | 7.78 | 22505724 | |
607 | Ubiquitination | FHATVATENEVFRVK EEEEEECCCCEEEEE | 41.47 | 24816145 | |
614 | Acetylation | ENEVFRVKVFNIDLK CCCEEEEEEEECCCC | 36.53 | 22691496 | |
614 | Phosphorylation | ENEVFRVKVFNIDLK CCCEEEEEEEECCCC | 36.53 | 27251275 | |
614 | Ubiquitination | ENEVFRVKVFNIDLK CCCEEEEEEEECCCC | 36.53 | - | |
618 | Ubiquitination | FRVKVFNIDLKEKFT EEEEEEECCCCCCCC | 4.45 | 23000965 | |
618 (in isoform 2) | Ubiquitination | - | 4.45 | 21906983 | |
621 | Acetylation | KVFNIDLKEKFTPKK EEEECCCCCCCCHHH | 55.92 | 23749302 | |
621 | Ubiquitination | KVFNIDLKEKFTPKK EEEECCCCCCCCHHH | 55.92 | - | |
623 | Ubiquitination | FNIDLKEKFTPKKII EECCCCCCCCHHHHH | 53.61 | - | |
624 | Ubiquitination | NIDLKEKFTPKKIIA ECCCCCCCCHHHHHH | 17.31 | 22505724 | |
625 | Ubiquitination | IDLKEKFTPKKIIAI CCCCCCCCHHHHHHH | 45.31 | 22505724 | |
626 | Ubiquitination | DLKEKFTPKKIIAIA CCCCCCCHHHHHHHH | 38.79 | 22505724 | |
627 | Ubiquitination | LKEKFTPKKIIAIAN CCCCCCHHHHHHHHH | 54.25 | 22505724 | |
628 | Ubiquitination | KEKFTPKKIIAIANY CCCCCHHHHHHHHHH | 40.31 | - | |
631 (in isoform 3) | Ubiquitination | - | 9.79 | 21906983 | |
632 | Ubiquitination | TPKKIIAIANYVCRN CHHHHHHHHHHHHHC | 1.47 | 22505724 | |
635 | Ubiquitination | KIIAIANYVCRNGFL HHHHHHHHHHHCCCE | 7.60 | 22817900 | |
639 | Ubiquitination | IANYVCRNGFLEVYP HHHHHHHCCCEEEEC | 40.20 | 22817900 | |
639 (in isoform 2) | Ubiquitination | - | 40.20 | 21906983 | |
640 | Ubiquitination | ANYVCRNGFLEVYPF HHHHHHCCCEEEECE | 14.79 | 22817900 | |
657 | Ubiquitination | VADVNADRNMEIPKG EEEECCCCCCCCCCH | 41.82 | 22505724 | |
659 | Ubiquitination | DVNADRNMEIPKGLI EECCCCCCCCCCHHH | 5.28 | 24816145 | |
660 | Ubiquitination | VNADRNMEIPKGLIR ECCCCCCCCCCHHHH | 60.74 | 22505724 | |
663 | Malonylation | DRNMEIPKGLIRSAS CCCCCCCCHHHHHCC | 72.51 | 26320211 | |
663 | Ubiquitination | DRNMEIPKGLIRSAS CCCCCCCCHHHHHCC | 72.51 | - | |
667 | Ubiquitination | EIPKGLIRSASVTPK CCCCHHHHHCCCCHH | 31.08 | 24816145 | |
668 | Phosphorylation | IPKGLIRSASVTPKI CCCHHHHHCCCCHHH | 20.22 | 29514088 | |
670 | Phosphorylation | KGLIRSASVTPKINQ CHHHHHCCCCHHHHH | 27.98 | 26074081 | |
672 | Phosphorylation | LIRSASVTPKINQLC HHHHCCCCHHHHHHH | 19.17 | 26074081 | |
674 | Malonylation | RSASVTPKINQLCSQ HHCCCCHHHHHHHHC | 44.94 | 32601280 | |
674 | Ubiquitination | RSASVTPKINQLCSQ HHCCCCHHHHHHHHC | 44.94 | 21906983 | |
674 (in isoform 1) | Ubiquitination | - | 44.94 | 21906983 | |
676 | Ubiquitination | ASVTPKINQLCSQTK CCCCHHHHHHHHCCC | 34.59 | 22505724 | |
678 | Ubiquitination | VTPKINQLCSQTKGS CCHHHHHHHHCCCCC | 2.34 | 22817900 | |
683 | Sumoylation | NQLCSQTKGSFVNGV HHHHHCCCCCEECEE | 44.94 | - | |
683 | Sumoylation | NQLCSQTKGSFVNGV HHHHHCCCCCEECEE | 44.94 | 28112733 | |
683 | Ubiquitination | NQLCSQTKGSFVNGV HHHHHCCCCCEECEE | 44.94 | - | |
687 | Ubiquitination | SQTKGSFVNGVFEVH HCCCCCEECEEEEEE | 6.98 | 22817900 | |
687 (in isoform 2) | Ubiquitination | - | 6.98 | 21906983 | |
695 | Acetylation | NGVFEVHKKNVRGEF CEEEEEEECCCCCEE | 51.74 | 25953088 | |
695 | Ubiquitination | NGVFEVHKKNVRGEF CEEEEEEECCCCCEE | 51.74 | 21906983 | |
695 (in isoform 1) | Ubiquitination | - | 51.74 | 21906983 | |
699 | Ubiquitination | EVHKKNVRGEFTYYE EEEECCCCCEEEEEE | 48.60 | 22817900 | |
700 | Ubiquitination | VHKKNVRGEFTYYEI EEECCCCCEEEEEEE | 30.04 | 22817900 | |
703 | Ubiquitination | KNVRGEFTYYEIQDN CCCCCEEEEEEEECC | 22.38 | 29967540 | |
704 | Phosphorylation | NVRGEFTYYEIQDNT CCCCEEEEEEEECCC | 12.38 | 22817900 | |
709 | Ubiquitination | FTYYEIQDNTGKMEV EEEEEEECCCCEEEE | 61.39 | 22505724 | |
711 | Ubiquitination | YYEIQDNTGKMEVVV EEEEECCCCEEEEEE | 46.60 | 24816145 | |
712 | Ubiquitination | YEIQDNTGKMEVVVH EEEECCCCEEEEEEE | 33.30 | 22505724 | |
719 | Phosphorylation | GKMEVVVHGRLTTIN CEEEEEEEEEEEEEE | 12.21 | 18669648 | |
720 | Phosphorylation | KMEVVVHGRLTTINC EEEEEEEEEEEEEEC | 18.06 | 20068231 | |
723 | Phosphorylation | VVVHGRLTTINCEEG EEEEEEEEEEECCCC | 25.03 | 27251275 | |
724 | Phosphorylation | VVHGRLTTINCEEGD EEEEEEEEEECCCCC | 18.13 | 24719451 | |
732 | Sumoylation | INCEEGDKLKLTCFE EECCCCCEEEEEEEE | 59.38 | - | |
732 | Acetylation | INCEEGDKLKLTCFE EECCCCCEEEEEEEE | 59.38 | 23749302 | |
732 | Ubiquitination | INCEEGDKLKLTCFE EECCCCCEEEEEEEE | 59.38 | - | |
734 | Sumoylation | CEEGDKLKLTCFELA CCCCCEEEEEEEEEC | 47.71 | - | |
734 | Acetylation | CEEGDKLKLTCFELA CCCCCEEEEEEEEEC | 47.71 | 23749302 | |
734 | Malonylation | CEEGDKLKLTCFELA CCCCCEEEEEEEEEC | 47.71 | 26320211 | |
734 | Ubiquitination | CEEGDKLKLTCFELA CCCCCEEEEEEEEEC | 47.71 | - | |
736 | Ubiquitination | EGDKLKLTCFELAPK CCCEEEEEEEEECCC | 17.35 | 22505724 | |
738 | Ubiquitination | DKLKLTCFELAPKSG CEEEEEEEEECCCCC | 7.90 | 22505724 | |
743 | Sumoylation | TCFELAPKSGNTGEL EEEEECCCCCCCHHH | 66.44 | - | |
743 | Ubiquitination | TCFELAPKSGNTGEL EEEEECCCCCCCHHH | 66.44 | 2190698 | |
743 (in isoform 1) | Ubiquitination | - | 66.44 | 21906983 | |
747 | Ubiquitination | LAPKSGNTGELRSVI ECCCCCCCHHHHHHH | 35.24 | 22817900 | |
759 | Acetylation | SVIHSHIKVIKTRKN HHHHHHHEEEECCCC | 32.27 | 23749302 | |
759 | Ubiquitination | SVIHSHIKVIKTRKN HHHHHHHEEEECCCC | 32.27 | - | |
767 | Ubiquitination | VIKTRKNKKDILNPD EEECCCCHHCCCCCC | 55.66 | - | |
768 | Ubiquitination | IKTRKNKKDILNPDS EECCCCHHCCCCCCC | 60.43 | - | |
769 | Ubiquitination | KTRKNKKDILNPDSS ECCCCHHCCCCCCCC | 52.82 | 22505724 | |
771 | Ubiquitination | RKNKKDILNPDSSME CCCHHCCCCCCCCCC | 12.49 | 24816145 | |
772 | Ubiquitination | KNKKDILNPDSSMET CCHHCCCCCCCCCCC | 38.37 | 22505724 | |
775 | Phosphorylation | KDILNPDSSMETSPD HCCCCCCCCCCCCCC | 32.61 | 25159151 | |
776 | Phosphorylation | DILNPDSSMETSPDF CCCCCCCCCCCCCCC | 28.19 | 25159151 | |
777 | Sulfoxidation | ILNPDSSMETSPDFF CCCCCCCCCCCCCCC | 8.25 | 30846556 | |
779 | Phosphorylation | NPDSSMETSPDFFF- CCCCCCCCCCCCCC- | 36.60 | 22115753 | |
780 | Phosphorylation | PDSSMETSPDFFF-- CCCCCCCCCCCCC-- | 14.79 | 26055452 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
132 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
132 | S | Phosphorylation | Kinase | CK2-FAMILY | - | GPS |
132 | S | Phosphorylation | Kinase | CK2_GROUP | - | PhosphoELM |
- | K | Ubiquitination | E3 ubiquitin ligase | ICP0 | P08393 | PMID:23427152 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of IF16_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of IF16_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-214, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-106 AND SER-153, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-106 AND SER-153, ANDMASS SPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-153, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-106, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-153, AND MASSSPECTROMETRY. |